Clinical Trials - CRDL

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06708299CardiolRx in Recurrent Pericarditis Following IL-1 Blocker CessationRECRUITINGPHASE32025-04-072026-10-212026-09-21
NCT05494788Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)COMPLETEDPHASE22022-11-302024-09-062024-06-15
NCT05180240Impact of CardiolRx on Myocardial Recovery in Patients With Acute MyocarditisCOMPLETEDPHASE22022-06-222025-02-042025-01-31
NCT04615949Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk FactorsTERMINATEDPHASE2, PHASE32021-04-302022-11-302022-11-30